DNAPrint Genomics, Inc. DNAG

Company Overview

DNAPrint Genomics, Inc. (OTC: DNAG) was a U.S.-based biotechnology and genetic testing company focused on ancestry analysis, molecular diagnostics, and pharmacogenomics. The company became known during the early 2000s for developing DNA-based ancestry testing products that sought to estimate an individual’s biogeographical heritage using genetic markers. DNAPrint Genomics operated within the broader biotechnology, genomics, and consumer genetic testing industries, with activities spanning research services, laboratory testing, and intellectual property development related to human genetics.

The company’s primary business activities included ancestry testing technologies, forensic and identity-related genetic analysis, and pharmaceutical research initiatives tied to personalized medicine. DNAPrint Genomics attempted to position itself as an early commercial participant in consumer genomics before the large-scale expansion of direct-to-consumer DNA testing companies. Public filings and historical market disclosures indicate that the company pursued strategic relationships in pharmaceuticals and diagnostics, although its operational scale remained limited compared with larger biotechnology firms. Over time, financial constraints, regulatory pressures, and operational difficulties reduced its market presence, and the company eventually became inactive in public markets based on available public disclosures.